22157.jpg
Non-Alcoholic Steatohepatitis (NASH) Pipeline Insight, 2024 Featuring 100+ Companies and 110+ Pipeline Drugs Including Lanifibranor (Inventiva Pharma), MSDC-0602K (Cirius Therapeutics), TERN-501 (Terns Pharma)
02 mai 2024 07h25 HE | Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
22157.jpg
Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Research Report 20254: Patient Pool Analysis, Market Size and Market Forecasts 2020-2034
13 févr. 2024 09h50 HE | Research and Markets
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The "Nonalcoholic Steatohepatitis (NASH) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ...
22157.jpg
Japan Non-Alcoholic Steatohepatitis (NASH) Market Forecast 2023-2032: Emerging Therapies & Treatment Insights, Comprehensive Market Outlook, Expert & Qualitative Analyses
30 janv. 2024 07h09 HE | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Japan Non-Alcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast - 2032" report has been added to ...
Logo.png
Nonalcoholic Steatohepatitis Clinical Trial Pipeline Analysis of 100+ Companies | NASH Pipeline Report by DelveInsight
23 mai 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, May 23, 2023 (GLOBE NEWSWIRE) -- Nonalcoholic Steatohepatitis Clinical Trial Pipeline Analysis of 100+ Companies | NASH Pipeline Report by DelveInsight Nonalcoholic steatohepatitis...
22157.jpg
Global Non-alcoholic Steatohepatitis (NASH) Market 2021-2038: Increased Competition from New Product Launches will Shape the NASH Market
23 mars 2021 08h08 HE | Research and Markets
Dublin, March 23, 2021 (GLOBE NEWSWIRE) -- The "Non-alcoholic steatohepatitis (NASH) Market and Forecast Analysis to 2038" report has been added to ResearchAndMarkets.com's offering. There are...
Logo.png
Nonalcoholic Steatohepatitis Drug Pipeline Analysis Review, 2020
13 janv. 2021 20h00 HE | DelveInsight Business Research LLP
Los Angeles, USA , Jan. 13, 2021 (GLOBE NEWSWIRE) -- Nonalcoholic Steatohepatitis Drug Pipeline Analysis Review, 2020  NASH Drug Pipeline Shows Promise as 95+ companies are working for...